Anjana Joel

7PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 24, 2025
Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched Analysis.

Praveen Kumar Marimuthu, Josh Thomas Georgy, Deepa Susan Joy Philip

|Jun 21, 2024
Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting.

Heber Rew Bright, Ashish Singh, Anjana Joel

|Jan 08, 2024
Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.

Rachel G Chandy, Vinotha Thomas, Ajit Sebastian

|Nov 01, 2023
Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer.

Ashish Singh, Josh Thomas Georgy, Anjana Joel

|Feb 09, 2023
End-of-Treatment FDG PET-CT (EOT-PET) in Patients with Post-Chemotherapy Masses for Seminoma: Can We Avoid Further Intervention?

Anjana Joel, Ashish Singh, Julie Hepzibah

|May 22, 2022
Diagnosis and management of 5-fluorouracil (5-FU)-induced acute leukoencephalopathy: lessons learnt from a single-Centre case series.

Neethu Jose, Anjana Joel, Rajesh Joseph Selvakumar

Pageof 2

Frequent Collaborators

4 joint publications

Josh Thomas Georgy

2 joint publications

Ashish Singh

2 joint publications

Ajoy Oommen John

1 joint publications

Rachel G Chandy